Profile of COVID-19 patients with renal and neurological dysfunctions
DOI:
https://doi.org/10.17267/2317-3378rec.2025.e6282Keywords:
COVID-19, Nervous System Diseases, Acute Kidney Injury, SARS-CoV-2Abstract
OBJECTIVE: To analyze the clinical and sociodemographic profile of patients with a confirmed diagnosis of COVID-19, as well as associated renal and neurological dysfunctions. METHODS: This is a descriptive, cross-sectional study with a quantitative approach, based on convenience sampling. Data collection was performed through the analysis of 271 physical and digital medical records of patients admitted to hospitals in the northern region of Minas Gerais, Brazil, between March and November 2020, using sociodemographic and clinical variables. Data were analyzed descriptively using the Statistical Package for the Social Sciences (SPSS), Windows version 27.0. RESULTS: A predominance of male patients (54.2%) and individuals identified as mixed race (“pardo”) (57.8%) was observed. Most patients were over 60 years of age (53.1%). Among patients infected with COVID-19, 21.0% presented neurological complications and 12.5% developed acute kidney injury. A total of 61 deaths (22.5%) were recorded, with the highest frequency among intubated patients (72.1%). Renal and neurological complications were mainly concentrated among patients over 60 years of age, accounting for 25.0% and 35.0%, respectively. CONCLUSIONS: The findings of this study highlight the occurrence of renal dysfunction and neurological complications primarily among hospitalized patients with COVID-19, especially those over 60 years old.
Downloads
References
1. Yang Y, Kim H, Hwang J. Quarantine facility for patients with COVID-19 with mild symptoms in Korea: Experience from eighteen residential treatment centers. J Korean Med Sci. 2020;35:e429. https://doi.org/10.3346/jkms.2020.35.e429
2. Ministério da Saúde. Secretaria de Vigilância em Saúde. Guia de vigilância epidemiológica: emergência de saúde pública de importância nacional pela doença pelo coronavírus 2019 – covid-19. [Internet]. Brasília: Ministério da Saúde; 2022. Available from: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/svsa/covid-19/guia-de-vigilancia-epidemiologica-covid-19_2021.pdf/view
3. Instituto Brasileiro De Geografia e Estatística (IBGE). Cidades e Estados [Internet]. Rio de Janeiro: IBGE; [citedo 2025 Feb. 5]. Available from: https://www.ibge.gov.br/cidades-e-estados/mg/montes-claros.html
4. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
5. Ministério da Saúde. Protocolo de manejo clínico do coronavírus (COVID-19) na atenção primária à saúde [Internet] Brasília: Ministério da Saúde; 2020. Available from: https://egestorab.saude.gov.br/image/?file=20200327_N_01ProtocoloManejover0620200327l_4724439690741830970.pdf
6. Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. Clinical course and outcome of 107 patients infected with the novel coronavirus, SARS-CoV-2, discharged from two hospitals in Wuhan, China. Crit Care. 2020;24:188. https://doi.org/10.1186/s13054-020-02895-6
7. Organização Mundial da Saúde (OMS). WHO COVID-19 dashboard [Internet]. Geneva: WHO; [cited 2020 sept. 15]. Available from: https://data.who.int/dashboards/covid19/cases
8. Ferreira YB, Freire FMR, Araujo VO, Oliveira IMP, Freitas LMOP, Santos JCC. Neurological manifestations associated with COVID-19: A review. Braz J Case Rep. 2021;1(4):31-44. https://doi.org/10.52600/2763-583X.bjcr.2021.1.4.31-44
9. Hui DSC, Zumla A. Severe acute respiratory syndrome: historical, epidemiologic, and clinical features. Infect Dis Clin North Am. 2019;33(4):869-89. https://doi.org/10.1016/j.idc.2019.07.001
10. Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the experience of clinical immunologists from China. Clin Immunol. 2020;214:108393. https://doi.org/10.1016/j.clim.2020.108393
11. Araujo EM, Caldwell KL, Santos MPA, Souza IM, Rosa PLFS, Santos ABS, et al. Covid-19 morbimortality by race/skin color/ethnicity: the Brazilian and the North American experiences. Saúde Debate. 2020;44(4):191-205. https://doi.org/10.1590/0103-11042020E412
12. Ahmadian E, Khatibi SMH, Soofiyani SR, Abediazar S, Shoja MM, Ardalan M, et al. Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2021;31(3):e2176. https://doi.org/10.1002/rmv.2176
13. Bienvenu LA, Noonan J, Wang X, Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020;116(14):2197-206. https://doi.org/10.1093/cvr/cvaa284
14. Nunes BP, Souza ASS, Nogueira J, Andrade FB, Thumé E, Teixeira DSC, et al. Multimorbidity and population at risk for severe COVID-19: Brazilian longitudinal study of aging. Cad Saude Publica. 2020;36(12):e00129620. https://doi.org/10.1590/0102-311X00129620
15. Organização Pan-Americana da Saúde. Coronavírus [Internet]. Washington: OPAS [cited 2022 Apr. 14]. Available from: https://www.paho.org/pt/topicos/coronavirus
16. Portolés J, Marques M, López-Sánchez P, Valdenebro M, Muñez E, Serrano ML, et al. Chronic kidney disease and acute kidney injury in the Covid-19 Spanish Outbreak. Nephrol Dial Transplant. 2020;35(8):1353-61. https://doi.org/10.1093/ndt/gfaa189
17. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in New York City area. JAMA. 2020;323(20):2098. https://doi.org/10.1001/jama.2020.6775
18. Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667-78. Erratum in: Lancet Gastroenterol Hepatol. 2020;5(7):e6. https://doi.org/10.1016/S2468-1253(20)30160-6
19. Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic Features in Severe SARS-CoV-2 Infection. N Engl J Med. 2020;382(23):2268-70. https://doi.org/10.1056/NEJMc2008597
20. Yadav R, Srivastava DK, Bajpai PK, Kumar R. Systemic review of CNS involvement and its manifestations in SARS-CoV2 positive patients. J Infect Public Health. 2021;14(6):734-9. https://doi.org/10.1016/j.jiph.2021.03.005
21. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-83. https://doi.org/10.1016/S1474-4422(20)30221-0
22. Fearon C, Fasano A. Parkinson's disease and the COVID-19 pandemic. J Parkinsons Dis. 2021;11(2):431-44. https://doi.org/10.3233/JPD-202320
23. Diao B, Wang C, Wang R, Feng Z, Tan Y, Wang H, et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. medRxiv. 2020:1-17. https://doi.org/10.1101/2020.03.04.20031120
24. Verstrepen K, Baisier L, Cauwer H. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol Belg. 2020;120(5):1051-60. https://doi.org/10.1007/s13760-020-01412-4
25. Ministério da Saúde. Cadastro Nacional de Estabelecimentos de Saúde – Indicadores de Leitos [Internet]. Brasília: DATASUS; [cited 2025 jan. 5]. Available from: https://cnes2.datasus.gov.br/Mod_Ind_Leitos_Listar.asp?VCod_Leito=02&VTipo_Leito=1&VListar=1&VEstado=31&VMun=&VComp=
26. Bialek S, Gierke R, Hughes M, McNamara LA, Pilishvili T, Skoff T. Coronavirus disease 2019 in children—United States, February 12–April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422–6. https://doi.org/10.15585/mmwr.mm6914e4
27. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. https://doi.org/10.1542/peds.2020-0702
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Aryanne Nayara Santos, Mariléia Chaves Andrade , Fernanda Santos Landim, Waldemar de Paula Junior, Ingredy Carolline de Jesus Santos, Andréa Maria Eleutério de Barros Lima Martins
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under a Creative Commons Attribution 4.0 International License.
